SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-048051
Filing Date
2017-09-14
Accepted
2017-09-14 16:10:37
Documents
3
Period of Report
2017-11-09
Effectiveness Date
2017-09-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A v475119_def14a.htm DEF 14A 289088
2 GRAPHIC v475119_proxy1.jpg GRAPHIC 193713
3 GRAPHIC v475119_proxy2.jpg GRAPHIC 145906
  Complete submission text file 0001144204-17-048051.txt   758507
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36641 | Film No.: 171085784
SIC: 2836 Biological Products, (No Diagnostic Substances)